Inactivation of transcription factor pit-1 to target tumoral somatolactotroph cells

Human Gene Therapy

Volumn 23, Issue 1, 2012, Pages 104-114

  Roche, Catherine ^a,b   Rasolonjanahary, Ramahefarizo ^a   Thirion, Sylvie ^a   Goddard, Isabelle ^a   Fusco, Alexandra ^a   Figarella Branger, Dominique ^b,c   Dufour, Henry ^a,b   Brue, Thierry ^a,b   Franc, Jean Louis ^a   Enjalbert, Alain ^a,b   Barlier, Anne ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^c University of the Mediterranean Aix Marseille II   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DNA; GROWTH HORMONE; LENTIVIRUS VECTOR; MUTANT PROTEIN; PROLACTIN; TRANSCRIPTION FACTOR PIT 1; TRYPTOPHAN;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER GENE THERAPY; CANCER INHIBITION; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG MECHANISM; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE MUTATION; GROWTH HORMONE RELEASE; GROWTH HORMONE SECRETING ADENOMA; GROWTH HORMONE SECRETING CELL; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS; HYPOPHYSIS CELL; LACTOTROPH CELL; MALE; MOUSE; NONHUMAN; PROLACTIN RELEASE; TRANSCRIPTION REGULATION; TUMOR CELL; TUMOR VOLUME; TUMOR XENOGRAFT; VIRAL GENE THERAPY; WILD TYPE;

ADENOMA; ANIMALS; ARGININE; BLOTTING, WESTERN; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMAN GROWTH HORMONE; HUMANS; LENTIVIRUS; MICE; MICE, NUDE; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; TRANSCRIPTION FACTOR PIT-1; TRANSCRIPTIONAL ACTIVATION; TRANSGENES; TRYPTOPHAN; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MURINAE; MUS MUSCULUS;

EID: 84855907169     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2011.105     Document Type: Article

References (44)

1. Aarskog, D., Eiken, H.G., Bjerknes, R., and Myking, O.L. (1997). Pituitary dwarfism in the R271W Pit-1 gene mutation. Eur. J. Pediatr. 156, 829-834. (Pubitemid 27463123)
2. Acunzo, J., Thirion, S., Roche, C., et al. (2008). Somatostatin receptor sst2 decreases cell viability and hormonal hypersecre-tion and reverses octreotide resistance of human pituitary adenomas. Cancer Res. 68, 10163-10170.
3. Acunzo, J., Roche, C., Defilles, C., et al. (2011) Inactivation of PITX2 transcription factor induced apoptosis of gonadotroph tumoral cells. Endocrinology 152, 3884-3892.
4. Alvarez, M., Rhodes, S.J., and Bidwell, J.P. (2003). Context-dependent transcription: all politics is local. Gene 313, 43-57. (Pubitemid 37338238)
5. Andersen, M., Bjerre, P., Schroder, H.D., et al. (2001). In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas. Clin. Endocrinol. (Oxf.) 54, 23-30. (Pubitemid 32158701)
6. Asa, S.L., Kovacs, K., Stefaneanu, L., et al. (1992). Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology 131, 2083-2089.
7. Asa, S.L., Puy, L.A., Lew, A.M., et al. (1993). Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas. J. Clin. Endocrinol. Metab. 77, 1275-1280. (Pubitemid 23345482)
8. Barlier, A., Gunz, G., Zamora, A.J., et al. (1998). Pronostic and therapeutic consequences of Gsa mutations in somatotroph adenomas. J. Clin. Endocrinol. Metab. 83, 1604-1610. (Pubitemid 28501029)
9. Ben-Batalla, I., Seoane, S., Garcia-Caballero, T., et al. (2010). Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasis. J. Clin. Invest. 120, 4289-4302.
10. Briata, P., Ilengo, C., Corte, G., et al. (2003). The Wnt/b-catenin/Pitx2 pathway controls the turnover of Pitx2 and other unstable mRNAs. Mol. Cell 12, 1201-1211. (Pubitemid 37487928)
11. Burton, F.H., Hasel, K.W., Bloom, F.E., and Sutcliffe, J.G. (1991). Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene. Nature 350, 74-77. (Pubitemid 21926125)
12. Canibano, C., Rodriguez, N.L., Saez, C., et al. (2007). The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth. EMBO J. 26, 2015-2028. (Pubitemid 46625783)
13. Castanotto, D., and Rossi, J.J. (2009). The promises and pitfalls of RNA-interference-based therapeutics. Nature 457, 426-433.
14. Castrillo, J.L., Theill, L.E., and Karin, M. (1991). Function of the homeodomain protein GHF1 in pituitary cell proliferation. Science 253, 197-199. (Pubitemid 21917141)
15. Chen, R.P., Ingraham, H.A., Treacy, M.N., et al. (1990). Auto-regulation of pit-1 gene expression mediated by two cis-active promoter elements. Nature 346, 583-586.
16. Cohen, L.E., Wondisford, F.E., Salvatoni, A., et al. (1995). A "hot spot" in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. J. Clin. Endocrinol. Metab. 80, 679-684.
17. Costoya, J.A., Garcia-Barros, M., Gallego, R., et al. (1998). Correlation of Pit-1 gene expression and Pit-1 content with proliferation and differentiation in human myeloid leukemic cells. Exp. Cell Res. 245, 132-136. (Pubitemid 28551062)
18. Daly, A.F., Tichomirowa, M.A., and Beckers, A. (2009). The epidemiology and genetics of pituitary adenomas. Best Pract. Res. Clin. Endocrinol. Metab. 23, 543-554.
19. De Paul, A.L., Gutierrez, S., Sabatino, M.E., et al. (2011). Epidermal growth factor induces a sexually dimorphic prolifer-ative response of lactotroph cells through protein kinase C-ERK1/2-Pit-1 in vitro. Exp. Physiol. 96, 226-239.
20. Dekkers, O.M., Biermasz, N.R., Pereira, A.M., et al. (2008). Mortality in acromegaly: a metaanalysis. J. Clin. Endocrinol. Metab. 93, 61-67.
21. Delhase, M., Vergani, P., Malur, A., et al. (1993). The transcription factor Pit-1/GHF-1 is expressed in hemopoietic and lymphoid tissues. Eur. J. Immunol. 23, 951-955. (Pubitemid 23101084)
22. Delhase, M., Castrillo, J.L., de la Hoya, M., et al. (1996). AP-1 and Oct-1 transcription factors down-regulate the expression of the human PIT1/GHF1 gene. J. Biol. Chem. 271, 32349-32358. (Pubitemid 26422276)
23. Gil-Puig, C., Seoane, S., Blanco, M., et al. (2005). Pit-1 is expressed in normal and tumorous human breast and regulates GH secretion and cell proliferation. Eur. J. Endocrinol. 153, 335-344. (Pubitemid 41167492)
24. Giustina, A., Chanson, P., Bronstein, M.D., et al. (2010). A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95, 3141-3148.
25. Jaquet, P., Gunz, G., and Grisoli, F. (1985). Hormonal regulation of prolactin release by human prolactinoma cells cultured in serum-free conditions. Horm. Res. 22, 153-163. (Pubitemid 15239625)
26. Lacerte, A., Lee, E.H., Reynaud, R., et al. (2004). Activin inhibits pituitary prolactin expression and cell growth through Smads, Pit-1 and menin. Mol. Endocrinol. 18, 1558-1569. (Pubitemid 38692190)
27. Li, S., Crenshaw, E.B., 3rd, Rawson, E.J., et al. (1990). Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347, 528-533.
28. Melmed, S. (2006). Medical progress: acromegaly. N. Engl. J. Med. 355, 2558-2573.
29. Miyai, S., Yoshimura, S., Iwasaki, Y., et al. (2005). Induction of GH, PRL, and TSHb mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line. Cell Tissue Res. 322, 269-277. (Pubitemid 41677643)
30. Ohta, K., Nobukuni, Y., Mitsubuchi, H., et al. (1992). Mutations in the Pit-1 gene in children with combined pituitary hormone deficiency. Biochem. Biophys. Res. Commun. 189, 851-855. (Pubitemid 23032452)
31. Pellegrini, I., Barlier, A., Gunz, G., et al. (1994). Pit-1 gene expression in the human pituitary and pituitary adenomas. J. Clin. Endocrinol. Metab. 79, 189-196. (Pubitemid 24221181)
32. Pellegrini, I., Roche, C., Quentien, M.H., et al. (2006). Involvement of the pituitary-specific transcription factor pit-1 in somato-lactotrope cell growth and death: an approach using dominant-negative pit-1 mutants. Mol. Endocrinol. 20, 3212-3227. (Pubitemid 44833566)
33. Pfaffl, M.W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45.
34. Pfäffle, R.W., DiMattia, G.E., Parks, J.S., et al. (1992). Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 257, 1118-1121.
35. Pirollo, K.F., and Chang, E.H. (2008). Targeted delivery of small interfering RNA: approaching effective cancer therapies. Cancer Res. 68, 1247-1250. (Pubitemid 351346828)
36. Radovick, S., Nations, M., Du, Y., et al. (1992). A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 257, 1115-1118.
37. Roche, C., Zamora, A.J., Taieb, D., et al. (2004). Lentiviral vectors efficiently transduce human gonadotroph and somatotroph adenomas in vitro. Targeted expression of transgene by pituitary hormone promoters. J. Endocrinol. 183, 217-233. (Pubitemid 40124658)
38. Romano, D., Magalon, K., Ciampini, A., et al. (2003). Differential involvement of the Ras and Rap1 small GTPases in vasoactive intestinal and pituitary adenylyl cyclase activating polypeptides control of the prolactin gene. J. Biol. Chem. 278, 51386-51394. (Pubitemid 38020378)
39. Romano, D., Magalon, K., Pertuit, M., et al. (2007). Conditional overexpression of the wild-type Gsa as the gsp oncogene initiates chronic extracellularly regulated kinase 1/2 activation and hormone hypersecretion in pituitary cell lines. Endocrinology 148, 2973-2983. (Pubitemid 46984797)
40. Saveanu, A., Lavaque, E., Gunz, G., et al. (2002). Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cells. J. Clin. Endocrinol. Metab. 87, 5545-5552. (Pubitemid 36034358)
41. Scully, K.M., Jacobson, E.M., Jepsen, K., et al. (2000). Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science 290, 1127-1131.
42. Solloso, A., Barreiro, L., Seoane, R., et al. (2008). GHRH prolifer-ative action on somatotrophs is cell-type specific and dependent on Pit-1/GHF-1 expression. J. Cell. Physiol. 215, 140-150. (Pubitemid 351363199)
43. Suh, H., Gage, P.J., Drouin, J., and Camper, S.A. (2002). Pitx2 is required at multiple stages of pituitary organogenesis: pituitary primordium formation and cell specification. Development 129, 329-337. (Pubitemid 34863800)
44. Voss, T.C., Demarco, I.A., Booker, C.F., and Day, R.N. (2005). Functional interactions with Pit-1 reorganize co-repressor complexes in the living cell nucleus. J. Cell Sci. 118, 3277-3288. (Pubitemid 41246085)